NASDAQ: GENE       Genetic Tech Spn Ads
Last Price Today's Change   Day's Range   Trading Volume
3.20   -0.17 (5.04%)  3.083 - 3.305  305,008


Avg Volume (4 weeks):532,480
4 Weeks Range:3.083 - 3.77
4 Weeks Price Volatility (%):
52 Weeks Range:1.408 - 10.30
52 Weeks Price Volatility (%):
Average Price Target: 7.50
Price Target Upside/Downside: +4.30


No recent Headlines for this stock.

Business Background

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women’s health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company’s revenue is generated from Australia and United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1785  4185  279  3150 

Top 10 Active Counters
 MGEN 1.26+0.74 
 TTNP 0.202+0.074 
 GE 7.715+0.615 
 LK 1.38+1.38 
 AAPL 112.95-3.65 
 OAS 0.155-0.014 
 SQQQ 24.13+2.07 
 NIO 27.552-0.888 
 NAKD 0.09-0.002 
 AMD 77.02-1.86